CB
CBD Life Sciences Inc.
CBDL · OTC
$0.00 -33.33% (-$0.00)
1M +100.00%
Market Cap $281.5K
P/E Ratio -
Div. Yield -
ROE 9.15%
Piotroski F-Score Weak
3/9Valuation
81 /100
Cheap P/B 0.37x
P/S 2.86x
EV/FFO N/A
Growth
22 /100
Declining Book val. growth 17.46%
Rev. growth 15.03%
FCF growth N/A
Profitability
17 /100
Weak Op. margin 103.44%
Gross margin 42.20%
FCF margin 141.53%
Quality
2 /100
Poor ROA 6.08%
ROIC 13.26%
Asset turnover 0.12x
Debt
100 /100
Low Current ratio 15.12x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
30 /100
Unstable EPS volatility 164.43%
Beta -0.59x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CBDL
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Lisa Anne Nelson
Employees
3
Headquarters
Scottsdale